Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Ovarian Carcinoma - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
Conditions: official terms
Carcinoma - Fallopian Tube Neoplasms - Neoplasms, Glandular and Epithelial - Ovarian Neoplasms
Conditions: Keywords
HIPEC, ovarian carcinoma, Bordet
Study Type
Study Phase
Phase 1/Phase 2
Study Design
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Type: Procedure
Overall Status
First line treatment for advanced ovarian carcinoma hyperthermic intraperitoneal chemotherapy (HIPEC) after optimal debulking.
Detailed Description
Addition of HIPEC to the standard first line treatment of ovarian carcinoma.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- stage III or only pleural stage IV ovarian carcinoma first line treatment

Exclusion Criteria:

- incomplete surgery poor performance status bad general condition
Institut Jules Bordet
Brussels, Belgium
Status: Recruiting
Contact: Joseph Kerger, M.D. - +3225413262 - joseph.kerger@bordet.be
Hopital de la Citadelle
Liège, Belgium
Status: Recruiting
Contact: Frédéric Goffin, M.D. - +3242257543 - fgoffin@chu.ulg.ac.be
Start Date
May 2010
Completion Date
November 2014
Jules Bordet Institute
Jules Bordet Institute
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page